Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) (PRaM-GBM)
Sponsor: CCTU- Cancer Theme
Listed as NCT03294434, this observational or N/A phase trial focuses on High Grade Glioma and remains completed. Sponsored by CCTU- Cancer Theme, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Oct 2024 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Feb 2022 — Jan 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Dec 2021 — Feb 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2019 — Nov 2020 [monthly]
Recruiting
-
May 2018 — Jul 2019 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CCTU- Cancer Theme
- Cambridge University Hospitals NHS Foundation Trust
- Cancer Research UK
- Experimental Cancer Medicine Centres
For direct contact, visit the study record on ClinicalTrials.gov .